CLOV vs OGN
Clover Health Investments Corp (CLOV) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CLOV currently screens at market cap $1.55B. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CLOV and OGN stock pages for the full models.
Not investment advice.